These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 530305)

  • 1. Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons?
    Euvrard C; Premont J; Oberlander C; Boissier JR; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):241-5. PubMed ID: 530305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.
    Memo M; Lovenberg W; Hanbauer I
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4456-60. PubMed ID: 6956874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum.
    Olianas MC; Onali P; Neff NH; Costa E
    J Neurochem; 1983 Nov; 41(5):1364-9. PubMed ID: 6619871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells.
    Maus M; Bertrand P; Drouva S; Rasolonjanahary R; Kordon C; Glowinski J; Premont J; Enjalbert A
    J Neurochem; 1989 Feb; 52(2):410-8. PubMed ID: 2521359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of a high-affinity GTPase in the inhibitory coupling of striatal muscarinic receptors to adenylate cyclase.
    Onali P; Olianas MC; Schwartz JP; Costa E
    Mol Pharmacol; 1983 Nov; 24(3):380-6. PubMed ID: 6138702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive changes in rat striatal preproenkephalin expression and dopamine-opioid interactions upon chronic haloperidol treatment during different developmental stages.
    De Vries TJ; Jonker AJ; Voorn P; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1994 Apr; 78(2):175-81. PubMed ID: 7913003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors.
    Bockaert J; Premont J; Glowinski J; Thierry AM; Tassin JP
    Brain Res; 1976 May; 107(2):301-15. PubMed ID: 1268730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
    Olianas MC; Onali P
    Neurosci Lett; 1987 Aug; 78(3):349-54. PubMed ID: 2819791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A; Rakovska A; Görcs T; Vizi ES
    Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):265-71. PubMed ID: 2331795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G; Porceddu ML; Spano PF; Gessa GL
    Brain Res; 1977 Jul; 130(2):374-82. PubMed ID: 884534
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenylate cyclase in striatal cholinergic interneurons regulates acetylcholine release.
    Login IS; Hewlett EL
    Brain Res; 1996 Oct; 735(2):330-4. PubMed ID: 8911674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
    Abbracchio MP; Colombo F; Di Luca M; Zaratin P; Cattabeni F
    Pharmacol Res Commun; 1987 Apr; 19(4):275-86. PubMed ID: 2889222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.